Nothing said here yet.
to join the conversation.
| Brosius MarkEVP & Chief Mfg and Supply Cha | Sell | 61 | $26.9K | Wed, Oct 28 |
| Brosius MarkEVP & Chief Mfg and Supply Cha | Sell | 61 | $27.5K | Tue, Oct 27 |
| Brosius MarkEVP & Chief Mfg and Supply Cha | Sell | 61 | $27.6K | Mon, Oct 26 |
| GUTHART GARY SDirector | Sell | 20,095 | $9.1M | Fri, Oct 23 |
| Widman FredrikVP Corporate Controller | Sell | 4,047 | $1.8M | Fri, Oct 23 |
| BARRATT CRAIG HDirector | Sell | 1,150 | $510.4K | Fri, Oct 23 |
| WADORS PATRICIA LSVP Chief Human Resources Offi | Sell | 1,078 | $478.4K | Fri, Oct 23 |
| Widman FredrikVP Corporate Controller | Sell | 546 | $204.4K | Tue, Sep 15 |
| Widman FredrikVP Corporate Controller | Sell | 543 | $203.3K | Tue, Sep 15 |
| Brosius MarkEVP & Chief Mfg and Supply Cha | Sell | 25 | $9.1K | Fri, Sep 11 |
| Brosius MarkEVP & Chief Mfg and Supply Cha | Sell | 23 | $8.0K | Thu, Sep 10 |
| Brosius MarkEVP & Chief Mfg and Supply Cha | Sell | 23 | $8.1K | Wed, Sep 9 |
| Alan Armstrong | Buy | $8.0K | Fri, Mar 27 | Tue, Jul 21 |
Intuitive Surgical's surging robotic surgery demand and stronger earnings momentum make it a better buy than Boston Scientific despite its valuation premium.
Intuitive Surgical's third-quarter sales surged 22%, outpacing procedure growth. Can system placements, new technologies and recurring revenues offset pricing pressures?
For questions about this article or underlying research, email [email protected].
Intuitive Surgical (ISRG) is back in focus after its latest earnings report, which paired higher quarterly revenue with lower net income and earnings per share, giving investors a mixed but important update on performance.
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable.
Intuitive Surgical (ISRG) possesses solid growth attributes, which could help it handily outperform the market.
Intuitive Surgical, Inc. (ISRG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
For questions about this article or underlying research, email [email protected].
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Key TakeawaysIntuitive Surgical shares fell 6% today after U. S.
For questions about this article or underlying research, email [email protected].
Intuitive Surgical stock came into Thursday with strong recent momentum, then slipped about 2% after the market had its first clean look at Q3 2026 numbers. The initial reaction focused on the headline gap between rich expectations and reality.